According to the predicting results of GEPIA online tool, HSPA8 was markedly higher expressed in CCA samples compared with normal samples (Fig. 3D), and the Co-IP results further verified that RPL35A directly acted on HSPA8 (Fig. 3E). The gene discussed is HSPA8; the disease is cholangiocarcinoma.